Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Conductivity Monitoring – V 2.0

Posted on By

Elixir Department: SOP for Conductivity Monitoring – V 2.0

Standard Operating Procedure for Conductivity Monitoring in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/202/2025
Supersedes SOP/ELX/202/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define a standardized procedure for monitoring conductivity during the elixir manufacturing process, ensuring water and solution quality compliance with pharmacopeial and regulatory specifications.

2. Scope

This SOP applies to all conductivity measurements of purified water, water for injection (WFI), and product solutions at various stages of elixir manufacturing within the Elixir Department.

3. Responsibilities

  • Production Operator:
    • Collect samples and perform basic conductivity checks using portable meters.
  • QC Analyst:
    • Perform conductivity verification on product solutions and water systems.
    • Record data and verify instrument calibration status.
  • QA Officer:
    • Review records and investigate any out-of-specification results.
See also  Elixir Department: SOP for Dispensing Excipients for Oral Liquid Formulations - V 2.0

4. Accountability

The QC Head is accountable for the accuracy of results. The Production Head is responsible for sampling compliance. QA Head ensures adherence to SOP and regulatory standards.

5. Procedure

5.1 Equipment and Calibration

  1. Use a calibrated digital conductivity meter with
temperature compensation capability.
  • Verify calibration using certified conductivity standards (e.g., 1.3 μS/cm and 5.0 μS/cm) before testing.
  • Record calibration details in the Instrument Calibration Logbook.
  • 5.2 Sampling Procedure

    1. Use clean and dry conductivity sampling bottles or measure directly from point-of-use when online meters are available.
    2. Collect samples from:
      • Purified water and WFI lines
      • Product solutions post-dissolution
      • Final bulk solution before filtration
    3. Label each sample with date, time, location, and sample point ID.

    5.3 Testing and Measurement

    1. Rinse the probe with the sample before immersing fully for measurement.
    2. Wait until the temperature and conductivity readings stabilize.
    3. Record conductivity value in μS/cm along with temperature.

    5.4 Acceptance Criteria

    1. Purified Water: NMT 1.3 μS/cm (as per IP/BP/USP standards at 25°C).
    2. WFI: NMT 1.1 μS/cm at 25°C.
    3. Elixir product solution: As specified in the BMR (typically ≤ 10 μS/cm unless product-specific).

    5.5 Action for Out-of-Specification Results

    1. Repeat testing using fresh sample.
    2. If OOS is confirmed, inform QA and initiate investigation.
    3. Hold product batch and water line until issue is resolved.

    5.6 Documentation

    1. Enter all data in the Conductivity Monitoring Logbook (Annexure-1).
    2. Attach calibration certificates and instrument printouts (if available).
    3. Ensure QA sign-off before batch release or water use approval.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • QC: Quality Control
    • BMR: Batch Manufacturing Record
    • WFI: Water for Injection

    7. Documents

    1. Conductivity Monitoring Logbook (Annexure-1)
    2. Instrument Calibration Logbook
    3. Batch Manufacturing Record (BMR)

    8. References

    • USP <645> – Water Conductivity
    • BP Monograph – Purified Water and WFI
    • 21 CFR Part 211.160 – Laboratory Controls

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Conductivity Monitoring Logbook

    Date Sample Point Batch No. Conductivity (μS/cm) Temperature (°C) Result Tested By QA Verified
    11/04/2025 WFI Line ELX-0425-021 0.95 25.1 Pass Rajesh Kumar Sunita Reddy

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Release New SOP QA Head
    11/04/2025 2.0 Included WFI and process solution sampling scope Regulatory Alignment QA Head
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Risks of Using Personal SOP Copies: A Hidden Threat to GMP Compliance
    Next Post: Analytical Method Development: SOP for Blend Uniformity Testing Method – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2026 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version